Newsletter

You are here

Health, Scientific progress

01 - 04 - 2016

Botox against neuropathic pain

A clinical trial with 152 patients with peripheral neuropathic has shown that botulium toxin, better known as Botox, has an analgesic effect on this type of pain. The test consisted of two injections spaced apart by 3 and 6 months of observation. The use of this therapy should be bound to hospitals considering the toxicity of the product. Animal studies and other clinical trials were behind the ideas that linked Botox with an analgesic activity.